Natus Medical to Hold 2012 Fourth Quarter Financial Results Conference Call on February 28
SAN CARLOS, Calif.--(BUSINESS WIRE)--
Natus Medical Incorporated (Nasdaq:BABY) today announced that the
Company intends to release its 2012 fourth quarter financial results
before the market opens on Thursday, February 28, 2013. Natus management
will host an investment-community conference call the same day beginning
at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those
results and to answer questions.
Individuals interested in listening to the conference call may do so by
dialing 866-783-2146 for domestic callers, or 1-857-350-1605 for
international callers, and entering reservation code 53672998. A
telephone replay will be available for 48 hours following the conclusion
of the call by dialing 888-286-8010 for domestic callers, or
1-617-801-6888 for international callers, and entering reservation code
58814594.
The conference call also will be available real-time via the Internet at ,
and a recording of the call will be available on the Company's Web site
for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products used for the
screening, detection, treatment, monitoring and tracking of common
medical ailments in newborn care, hearing impairment, neurological
dysfunction, epilepsy, sleep disorders, and balance and mobility
disorders. Product offerings include computerized neurodiagnostic
systems for audiology, neurology, polysomnography, and neonatology, as
well as newborn care products such as hearing screening systems,
phototherapy devices for the treatment of newborn jaundice, head-cooling
products for the treatment of brain injury in newborns, incubators to
control the newborn's environment, and software systems for managing and
tracking disorders and diseases for public health laboratories.
Additional information about Natus Medical can be found at .
Natus Medical Incorporated Steven J. Murphy Vice President
Finance and Chief Financial Officer 650-802-0400 InvestorRelations@Natus.com
Press Release $BABY Natus Medical Inc.
SAN CARLOS, Calif.--(BUSINESS WIRE)-- Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company intends to release its 2012 fourth quarter financial results before the market opens on Thursday, February 28, 2013. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 866-783-2146 for domestic callers, or 1-857-350-1605 for international callers, and entering reservation code 53672998. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 58814594.
The conference call also will be available real-time via the Internet at , and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.
Additional information about Natus Medical can be found at .
Natus Medical Incorporated
Steven J. Murphy
Vice President Finance and Chief Financial Officer
650-802-0400
InvestorRelations@Natus.com
Source: Natus Medical Incorporated